NCT06315855

Brief Summary

The investigators will conduct a 2-arm 6-month randomized clinical controlled trial to evaluate the effectiveness of an oral Telehealth Intervention (THI) in preventing cancer-related oral complications, improving oral health maintenance and oral health related quality of life, and reducing systemic inflammation compared to Usual Care (UC) among unselected cancer survivors.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
16mo left

Started Aug 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Aug 2024Aug 2027

First Submitted

Initial submission to the registry

February 15, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 18, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

August 20, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 25, 2027

Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

2 years

First QC Date

February 15, 2024

Last Update Submit

January 20, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • mucositis

    The World Health Organization Oral Toxicity Scale rates the anatomical, and function aspects of oral mucositis. The severity of oral ulcers and ability to consume food and liquid is reported on a scale of 0 (no presentation of symptoms) to 4 (not able to tolerate food or liquid diet). Higher scores indicate worse oral mucositis symptomology. The PROMS questionnaire: Respondents will indicate their level of oral mucositis symptoms on a sliding scale ranging from no experience of a mucositis-related symptoms to complete experience of symptoms. Higher scores indicate worse self-reported mucositis.

    baseline and repeated at 6 and 12 months

  • gingival inflammation and periodontal disease

    Using the modified gingival index, the investigators will rate inflammation of gums on a 5-point Likert Scale ranging from 0 (absence of inflammation) to 4(severe inflammation, marked redness, edema. Higher scores indicate more severe inflammation.

    baseline and repeated at 6 and 12 months

  • tooth decay

    Delayed, Missing, Filled Teeth (DMFT) index based on intraoral imaging The DMFT index will be calculated by summing the number of delayed, missing, or filled teeth and dividing this value by the sum of the DMFT values in the study sample. Higher values equate to poorer tooth retention.

    baseline and repeated at 6 and 12 months

  • oral health related quality of life

    Oral health Impact Profile (14-item OHIP-14 questionnaire) and the cancer specific oral health questionnaires (EORTC Quality of Life Questionnaires - oral health) This measure assesses the impact of oral health on overall wellbeing. Respondents will indicate their agreement with a statement (Yes/No). Higher scores indicate a greater impact of oral health on daily life. EORTC- Quality of Life Questionnaires Oral health: For items 1-11, Respondents indicate agreements on a 4-point Likert scale ranging from 1(not at all) to 4(Very much). On items 12-15, respondents indicate dichotomous agreement (Yes/No). Scores are summed and logged transformed to 0-100 scale. Higher scores indicate a better oral health related quality of life and better functioning.

    baseline and repeated at 6 and 12 months

Secondary Outcomes (3)

  • systemic inflammation

    baseline and repeated at 6 and 12 months

  • overall health related quality of life

    baseline and repeated at 6 and 12 months

  • comorbidities

    baseline and repeated at 6 and 12 months

Study Arms (2)

Telehealth Intervention (THI) arm

EXPERIMENTAL

The THI is a 6-month intervention. Participants randomized to THI arm will engage in 6,1-hour virtual sessions with trained study personnel. Modules contain a 1) participant check-in, 2) content designed to build oral health literacy and self-efficacy, 3) and goal-setting. Coaches will use a facilitation guide, layered with motivational interviewing to conduct telehealth sessions. Participants will also receive biweekly text messages aligned with module content. Post-intervention follow-up will occur at 6- and 12-month post-randomization.

Behavioral: Telehealth Intervention (THI)

Usual Care (UC) arm

NO INTERVENTION

This group will receive biweekly text messages on general health behaviors as a retention strategy. This arm will receive no other outside interventions. The Dental Resource directory will be provided to all participants.

Interventions

The THI is a 6-month intervention. On a monthly basis, the survivor will be queried via telehealth (zoom or smart phone) oral and health related symptoms by nurse practitioner or navigator. Based on the initial imaging and the monthly assessments, the patients will be provided with tools and instructions for oral health maintenance which may consist of mucositis management and/or diet and lifestyle counseling. All participants will be provided a Resource directory that is to be used to identify a dentist that is best suited for him/her. Post intervention, follow-up assessments will be conducted at 6-, 9- and 12-months post randomization.

Telehealth Intervention (THI) arm

Eligibility Criteria

Age25 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • male and female cancer survivors who are either ≥ 6 months after competing primary therapy for cancer treatment (N=100)
  • between 25-75 years of age
  • all race/ethnic groups
  • own a smart phone.

You may not qualify if:

  • all head and neck/oral cancer survivors
  • less then 25 years and older than 75 years of age
  • recurrence/second cancers or undergoing treatment
  • unable to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Georgetown Lombardi Office of Minority Health

Washington D.C., District of Columbia, 20003, United States

RECRUITING

Related Publications (1)

  • Dash C, Smith DI, Williams N, Leby C, Nyirenda N, Makambi KH, Adams-Campbell L. The FLOSS Project: study protocol for a parallel-group, two-arm randomized controlled trial examining the efficacy of telehealth in promoting oral and systemic health in cancer survivors. Trials. 2025 Nov 24;26(1):535. doi: 10.1186/s13063-025-09247-1.

MeSH Terms

Conditions

StomatitisPeriodontal DiseasesNeoplasms

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2024

First Posted

March 18, 2024

Study Start

August 20, 2024

Primary Completion (Estimated)

August 25, 2026

Study Completion (Estimated)

August 25, 2027

Last Updated

January 22, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations